ArticleNeuromolecular medicine2013

The diabetes drug liraglutide ameliorates aberrant insulin receptor localisation and signalling in parallel with decreasing both amyloid-β plaque and glial pathology in a mouse model of Alzheimer's disease.

Caitriona M Long-Smith et al.PubMed ↗Publisher ↗

No numbers read from the abstract.